# Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

> **NCT07225387** · PHASE4 · RECRUITING · sponsor: **NephroNet, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Voclosporin

## Key facts

- **NCT ID:** NCT07225387
- **Lead sponsor:** NephroNet, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-01
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07225387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07225387, "Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07225387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*